Mice genetically deficient in the pleiotropic cytokine interleukin-6 (IL-6) exhibit immunodeficiency against viral, bacterial, and fungal pathogens. When challenged with the protozoan parasite Leishmania major, IL-6-deficient mice controlled infection and mounted strong Th1 responses as efficiently as IL-6-sufficient littermates. Thus, the successful activation of parasitized macrophages and class II-restricted T cells does not require a full inflammatory repertoire.
, and susceptible BALB/c mice were inoculated with 5 ϫ 10 5 metacyclic promastigotes of L. major (strain WHOM/IR/-/173) in each hind footpad. Infections were monitored with weekly measurements for 6 weeks, using a metric caliper. IL-6 Ϫ/Ϫ mice controlled infection as well as ϩ/Ϫ mice, as determined by resolution of footpad swelling (Fig. 1) . Both IL-6 ϩ/Ϫ and IL-6 Ϫ/Ϫ mice had a disease course that sharply contrasted with that of BALB/c mice, which developed severe and progressive footpad lesions (Fig. 1) . To assess the microbiologic outcome for the mutant animals, quantitative cultures were performed on the feet and spleens of infected mice. Tissues were homogenized in a fixed volume of parasite medium M199 (Fisher Scientific, Pittsburgh, Pa.) supplemented with 20% fetal calf serum and aliquoted to a flat-bottom 96-well plate. Samples were then diluted serially across the plate and stored at 26°C for 2 weeks. The feet and spleens of IL-6 Ϫ/Ϫ mice had parasite loads equivalent to or lower than those of the matched tissues of IL-6 ϩ/Ϫ mice. Susceptible BALB/c mice had parasite burdens greater than 3 orders of magnitude higher than those of both IL-6 Ϫ/Ϫ and IL-6 ϩ/Ϫ mice (Fig. 2) . IL-6, therefore, is not required for healing and resolution of infection with L. major.
To ascertain whether IL-6 deficiency had an adverse impact on Th1 differentiation, as has been reported in other systems (17) , draining popliteal lymph nodes of IL-6 Ϫ/Ϫ and IL-6 ϩ/Ϫ animals were removed for analysis of cytokine production. Single-cell suspensions were made, and triplicate aliquots of 10 6 cells/well were placed in 96-well plates with Iscove's medium (Fisher Scientific) or medium plus 100 g of soluble Leishmania antigen per ml. After 48 h, supernatants were * Corresponding author. Mailing address: Gwen Knapp Center, University of Chicago, 924 E. 57th St., Chicago, IL 60637-5420. collected and analyzed by enzyme-linked immunosorbent assay using commercial antibody pairs (Pharmingen, San Diego, Calif.). Antigen-specific IFN-␥ production was equivalently high among individual IL-6 ϩ/Ϫ and IL-6 Ϫ/Ϫ animals ( Fig. 3 ). BALB/c mice produced less IFN-␥ in response to antigen than the healer animals. There was no detectable IFN-␥ in any wells without added antigen.
To assess the in vivo pattern of T helper differentiation, we performed competitive quantitative reverse transcription-PCR as described previously (16) . Briefly, total RNA was extracted from popliteal lymph nodes taken directly from infected animals by using RNAzol (Cinna/Biotecx, Houston, Tex.) and reverse transcribed by using random hexamer primers. A competitor molecule containing mutated cDNAs approximately 30% larger than wild-type transcripts was used as an internal control for amplification. Concentrations of cDNA were equalized by amplifying the constitutively expressed HPRT gene. Adjusted volumes of cDNA were then used in subsequent reactions with primers specific for IFN-␥ and IL-4. PCRs were resolved on ethidium-stained agarose gels. The IL-6 Ϫ/Ϫ and IL-6 ϩ/Ϫ animals all had elevated levels of IFN-␥ mRNA and lower levels of IL-4 mRNA compared to susceptible BALB/c mice (Fig. 4) . IL-6, therefore, is not required for strong Th1 responses against L. major.
IL-6-deficient mice have enhanced susceptibility to infection with vaccinia virus (12) , Listeria monocytogenes (5, 12), and C. albicans (17) . Control of these infections is associated with effector functions ascribed to cell-mediated immunity. Although infection with L. major represents another well-characterized example of the cell-mediated control of intracellular parasitization (15), we could find no impairment in the resistance of IL-6 Ϫ/Ϫ mice to parasite challenge. It is possible that IL-6 plays a negative role in the control of L. major. This would be consistent with the ability of IL-6 to inhibit antileishmanial macrophage activation in vitro (9) . It may be easier, however, to implicate IL-6 as a negative regulator of antileishmanial immunity if BALB/c IL-6 Ϫ/Ϫ mice display enhanced resistance to L. major.
Neutrophils have been shown to play an important role in control of C. albicans (17) and Listeria monocytogenes (3, 4) . IL-6-deficient mice infected with either Candida or Listeria have reduced peripheral blood neutrophilia (5, 17) . Furthermore, administration of recombinant IL-6 to Candida-infected and Listeria-infected mice restored neutrophilia and increased resistance to disease (5, 17) . Thus, inefficient neutrophilia resulting from lack of IL-6 may be of major consequence in candidiasis or listeriosis but inconsequential to the resolution of leishmaniasis owing to the limited intramammalian habitat of the parasite.
Assessment of other proinflammatory mediators has also revealed differential requirements among various models of cell-mediated immunity. TNF receptor 1 (p55) Ϫ/Ϫ mice have enhanced susceptibility to Listeria monocytogenes (14, 18) and Mycobacterium tuberculosis (7) , suggesting an important contribution of TNF-␣ in the control of intracellular infection. TNF-␣ also synergizes with IL-12 to promote IFN-␥ production from NK cells (8, 21) . TNF receptor 1 (p55) Ϫ/Ϫ mice, however, exhibit full resistance to L. major (22) , suggesting, again, that the requirements for eradication of an exclusively intramacrophagic organism may be less stringent than for microbes with more complex life cycles. It may be of interest to challenge IL-1-deficient mice with L. major in order to fully exclude a contribution by the proinflammatory triad in control of this organism. 
